NasdaqGS - Nasdaq Real Time Price USD

The Cooper Companies, Inc. (COO)

Compare
103.75 +0.42 (+0.41%)
At close: November 8 at 4:00 PM EST
103.75 0.00 (0.00%)
After hours: November 8 at 4:25 PM EST
Loading Chart for COO
DELL
  • Previous Close 103.33
  • Open 103.45
  • Bid 103.62 x 100
  • Ask 111.85 x 200
  • Day's Range 103.00 - 104.57
  • 52 Week Range 81.99 - 112.38
  • Volume 646,229
  • Avg. Volume 1,142,484
  • Market Cap (intraday) 20.662B
  • Beta (5Y Monthly) 0.99
  • PE Ratio (TTM) 57.96
  • EPS (TTM) 1.79
  • Earnings Date Dec 5, 2024 - Dec 9, 2024
  • Forward Dividend & Yield 0.02 (0.02%)
  • Ex-Dividend Date Jul 26, 2023
  • 1y Target Est 113.94

The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific. The CooperSurgical segment focuses on family and women's health care, which provides fertility products and services, medical devices, and contraception, as well as cryostorage, such as cord blood and cord tissue storage to health care professionals and patients worldwide. It offers surgical and office products, including endosee endometrial imaging products, fetal pillow cephalic elevation devices for use in cesarean sections, illuminated speculum products, lone star retractor systems, loop electrosurgical excision procedure products, mara water ablation systems, paragard contraceptive IUDs, point-of-care, and uterine positioning products, as well as cryostorage, such as cord blood and cord tissue storage; fertility products and services, such as fertility consumables and equipment, donor gamete services, and genomic services, including genetic testing. The company sells its products to distributors, group purchasing organizations, eye care and health care professionals, including independent practices, corporate retailers, hospitals and clinics, and authorized resellers. The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon, California.

www.coopercos.com

15,000

Full Time Employees

October 31

Fiscal Year Ends

Recent News: COO

View More

Performance Overview: COO

Trailing total returns as of 11/8/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

COO
9.66%
S&P 500
25.70%

1-Year Return

COO
24.34%
S&P 500
36.94%

3-Year Return

COO
2.14%
S&P 500
27.63%

5-Year Return

COO
40.89%
S&P 500
94.33%

Compare To: COO

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: COO

View More

Valuation Measures

Annual
As of 11/8/2024
  • Market Cap

    20.66B

  • Enterprise Value

    23.19B

  • Trailing P/E

    57.72

  • Forward P/E

    25.77

  • PEG Ratio (5yr expected)

    10.51

  • Price/Sales (ttm)

    5.46

  • Price/Book (mrq)

    2.61

  • Enterprise Value/Revenue

    6.09

  • Enterprise Value/EBITDA

    22.94

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    9.44%

  • Return on Assets (ttm)

    3.39%

  • Return on Equity (ttm)

    4.65%

  • Revenue (ttm)

    3.8B

  • Net Income Avi to Common (ttm)

    359.3M

  • Diluted EPS (ttm)

    1.79

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    109.7M

  • Total Debt/Equity (mrq)

    36.71%

  • Levered Free Cash Flow (ttm)

    148.78M

Research Analysis: COO

View More

Earnings Per Share

Consensus EPS
 

Revenue vs. Earnings

Revenue 1B
Earnings 104.7M
Q3'23
Q4'23
Q1'24
Q2'24
0
200M
400M
600M
800M
1B
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Analyst Price Targets

92.12 Low
113.94 Average
103.75 Current
130.00 High
 

Company Insights: COO

Research Reports: COO

View More
  • What does Argus have to say about COO?

    COOPER COS INC/THE has an Investment Rating of HOLD; a target price of $110.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Medium.

    Rating
    Price Target
     
  • Lowering target price to $110.00

    COOPER COS INC/THE has an Investment Rating of HOLD; a target price of $110.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Medium.

    Rating
    Price Target
     
  • Lowering target price to $111.00

    COOPER COS INC/THE has an Investment Rating of HOLD; a target price of $111.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Medium.

    Rating
    Price Target
     
  • Raising target price to $114.00

    COOPER COS INC/THE has an Investment Rating of HOLD; a target price of $114.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Medium.

    Rating
    Price Target
     

People Also Watch